Search Results 361-370 of 16272 for pharmacogenetics
In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...
A Study to Evaluate Combination Therapy to Treat Newly-diagnosed Diffuse Anaplastic Wilms Tumors and Relapsed Favorable Histology Wilms Tumors A Study of ...
Review the student roster and career outcomes of the Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Her residency training in Internal Medicine and Medical Biochemistry was completed at McMaster University in Hamilton, Ontario. She worked in IT for several ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
Cancer therapy and clinical trials. Development of antitumor agents. Drug metabolism. Epidemiology. Inflammatory bowel disease. Mechanism of action of drugs.
About this study. The purpose of this study is to establish at least 200 patient-derived cancer xenografts (PDXs), and to utilize these PDXs in preclinical ...
Since its completion in 2003, the project has paved the way for scientists to gather knowledge about a patient's genome to diagnose, predict, treat and prevent ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.